Fenwick & West advised ACELYRIN, INC. on the transaction, and Cooley advised Alumis Inc. ACELYRIN, INC. (Nasdaq: SLRN), a late-stage clinical biopharma company focused on accelerating...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented EngageSmart, while Fenwick & West advised the underwriters on the deal. EngageSmart (NYSE: ESMT) announced its initial public offering. The company is a leading...
You must be a Standard 1 Year member to access this content.
Latham & Watkins LLP is serving as legal advisor to Inovalon and the Special Committee of the Board of Directors of Inovalon. Kirkland & Ellis represented...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Ginger on the deal, while Latham & Watkins represented Headspace. Ginger, a leading provider of on-demand mental healthcare, and Headspace, a...
You must be a Standard 1 Year member to access this content.
Latham & Watkins LLP represented SoftBank Vision Fund 2 in the transaction. SambaNova Systems, the company building advanced software, hardware and services to run AI applications,...
You must be a Standard 1 Year member to access this content.
Latham & Watkins LLP represented SQZ Biotechnologies Company in the transaction. SQZ Biotechnologies Company (NYSE: SQZ) (SQZ), a cell therapy company developing novel treatments for multiple...
You must be a Standard 1 Year member to access this content.
